Indications and uses
for the temporary relief of these symptoms associated with menstrual periods: cramps bloating water-weight gain headache backache muscle aches fatigue
Buscapina
- Manufacturer
- OPMX LLC
- Effective date
- 2026-11-04
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- daily-update
- Hydrated at
- 2026-11-07 03:02:17
Label at a glance#
ProductBuscapina
Active ingredientPYRILAMINE MALEATE, ACETAMINOPHEN, CAFFEINE
Label structure8 sections
Dosage and administration
do not exceed recommended dosage adults and children 12 years and over: take 2 caplets with water. Repeat every 6 hours as needed. Do not exceed 6 caplets per day. children under 12 years: consult a doctor
Storage and handling
store at room temperature 68-77°F (20-25°C) TAMPER EVIDENT: DO NOT USE IF PACKAGE IS OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGN OF TAMPERING
Contacts and useful links#
Label contents#
Full prescribing information#
Active ingredients
Purpose
| Active Ingredients (in each caplet) | Purpose |
| Acetaminophen 500mg | Pain reliever |
| Caffeine 60mg | Diuretic |
| Pyrilamine maleate 15mg | Antihistamine |
Uses
for the temporary relief of these symptoms associated with menstrual periods:
- cramps
- bloating
- water-weight gain
- headache
- backache
- muscle aches
- fatigue
Warnings
Liver warning:
This product contains acetaminophen. Severe liver damage may occur if you take:
- more than 6 caplets in 24 hours, which is the maximum daily amount for this product
- with other drugs containing acetaminophen
- 3 or more alcoholic drinks every day while using this product
Allergy alert
Acetaminophen may cause severe skin or severe allergic reactions. Symptoms may include: •
- skin reddening
- blisters
- rash
- hives
- facial swelling
- asthma (wheezing)
- shock
If a skin or general allergic reaction occurs, stop use and seek medical help right away.
Do not use
- with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen ask a doctor or pharmacist
- if you have ever had an allertgic reaction to this product or any of its ingredients
Ask a doctor before use if you have
- liver disease
- glaucoma
- difficulty in urination due to enlargement of the prostate gland
- a breathing problem such as emphysema or chronic bronchitis
Ask a doctor or pharmacist before use if you are
- taking the blood thinning drug warfarin
- taking sedatives or tranquilizers
When using this product
- you may get drowsy
- avoid alcoholic drinks
- excitability may occur, especially in children
- alcohol, sedatives, and tranquilizers may increase drowsiness
- be careful when driving a motor vehicle or operating machinery
- limit the use of caffeine-containing medications, foods, or beverages because too much caffeine may cause nervousness, irritability sleeplessness, and, occasionally rapid heartbeat. The recommended dose of this product contains about as much caffeine as a cup of coffee.
Stop use and ask a doctor if
- new symptoms appear
- redness or swelling is present
- pain gets worse or lasts for more than 10 days
- fever gets worse or lasts for more than 3 days
If pregnant or breast-feeding
ask a health professional before use.
Keep out of reach of chlidren.
In case of overdose, get medical help or contact a Poison Control Center right away. Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
Directions
- do not exceed recommended dosage
- adults and children 12 years and over: take 2 caplets with water. Repeat every 6 hours as needed. Do not exceed 6 caplets per day.
- children under 12 years: consult a doctor
Other information
- store at room temperature 68-77°F (20-25°C)
- TAMPER EVIDENT: DO NOT USE IF PACKAGE IS OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGN OF TAMPERING
Inactive ingredients
colloidal silicon dioxide, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, pvp K-30, sodium starch glycolate, stearic acid, talc, titanium dioxide
Questions or comments?
Call toll free 619-600-5632
Monday through Friday 9AM - 5PM EST
Buscapina 6 caplets
Buscapina
Acetaminophen, Caffeine, Pyrilamine Maleate Tablets
NDC 69729-132-06
- Cramps
- Bloating
- Fatigue
- Heacache
- Backache
6 Caplets
3 packs of 2 Caplets
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0810053181249 | GTIN-13: 0810053181249 EAN-13: 0810053181249 GTIN-12: 810053181249 UPC-A: 810053181249 GTIN storage (14 digits): 00810053181249 | Buscapina w6 Caplets (nuevo suaje) - Rev. 08.2023 (002)_001.jpg |
| QR code link | QR Code |  opmx.us/ | Buscapina w6 Caplets (nuevo suaje) - Rev. 08.2023 (002)_001.jpg |
DailyMed Product Concepts#
Products#
Every source-derived product name is available through these pages.
- Buscapina
- Acetaminophen, Caffeine, Pyrilamine Maleate
- PYRILAMINE MALEATE
- PYRILAMINE
- ACETAMINOPHEN
- CAFFEINE
- SILICON DIOXIDE
- STARCH, CORN
- MAGNESIUM STEARATE
- POVIDONE K30
- STEARIC ACID
- HYPROMELLOSE, UNSPECIFIED
- TALC
- MICROCRYSTALLINE CELLULOSE
- SODIUM STARCH GLYCOLATE TYPE A
- POLYETHYLENE GLYCOL, UNSPECIFIED
- TITANIUM DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 69729-132 | 69729-132-06 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Older Hydrated Versions#
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 2 | 2024-12-03 | full-release | 2026-06-01 00:40:18 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Buscapina | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | OPMX LLC | 048c4b03-1cf4-b724-e063-6294a90a1cad | 2024-12-03 | Warnings | 69729-132-06 69729-132 69729013206 048c4b03-1cf4-b724-e063-6294a90a1cad |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.